Rollins Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328K Buy
2,728
+10
+0.4% +$1.15K 0.05% 128
2025
Q4
$286K Buy
2,718
+12
+0.4% +$1.13K 0.04% 127
2025
Q3
$227K Buy
2,706
+12
+0.4% +$988 0.03% 138
2025
Q2
$213K Buy
2,694
+13
+0.5% +$1.03K 0.03% 134
2025
Q1
$241K Sell
2,681
-822
-23% -$76.7K 0.04% 115
2024
Q4
$349K Buy
3,503
+8
+0.2% +$825 0.05% 99
2024
Q3
$397K Buy
3,495
+2
+0.1% +$238 0.07% 89
2024
Q2
$432K Buy
3,493
+1,322
+61% +$170K 0.07% 80
2024
Q1
$286K Buy
+2,171
New +$268K 0.05% 97

Other funds holding MRK

Rollins Financial Advisors's MRK Position: Q1 2026 in Review

Rollins Financial Advisors increased its Merck (MRK) stake by 0.37% in Q1 2026, buying an estimated $1.15K and bringing the position to 2,728 shares worth $328K. The position accounts for 0.05% of the portfolio, ranked #128.

Rollins Financial Advisors first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. The position peaked at $432K in Q2 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Rollins Financial Advisors held 2,728 shares of Merck worth $328K as of Q1 2026.
  • Rollins Financial Advisors bought 10 Merck shares in Q1 2026, an estimated $1.15K.
  • Merck made up 0.05% of Rollins Financial Advisors's portfolio in Q1 2026, its #128 holding.
  • Rollins Financial Advisors first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • Rollins Financial Advisors's Merck position peaked at $432K in Q2 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Rollins Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.